RAYZEBIO
Live / Applied — Statement of use — processing complete, to examiner (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 27 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97242274
- Mark type
- Design + words
- Filed
- 27 Jan 2022
- Published for opposition
- 10 Jan 2023
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; diagnostic agents, preparations and substances for medical purposes; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use
Owner
- RayzeBio, Inc., San Diego, CA, US
- RayzeBio, Inc., San Diego, CA, US
Prosecution history
- 12 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Sept 2025 — USE AMENDMENT FILED
- 12 Mar 2026 — SOU EXTENSION 5 GRANTED
- 02 Sept 2025 — SOU EXTENSION 5 FILED
- 11 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 02 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2025 — SOU EXTENSION 4 GRANTED
- 07 Mar 2025 — SOU EXTENSION 4 FILED
- 07 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED